Opaleye Management Inc. Intra Cellular Therapies, Inc. Transaction History

Opaleye Management Inc.

  • $390 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $5.01 Million - $13.5 Million
-406,600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $1.72 Million - $9.11 Million
236,600 Added 139.18%
406,600 $14 Million
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $1.27 Million - $2.39 Million
170,000 New
170,000 $1.27 Million

Others Institutions Holding ITCI

# of Institutions
398
Shares Held
87.5M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email